In the tumour context, the cGAS/STING pathway appears to be the major innate immune DNA sensing pathway that drives dendritic cells (DCs) activation and subsequent T-cell priming against tumour-associated antigens in vivo [11]. The gene discussed is CGAS; the disease is neoplasm.